University of Paris-Sud and University Paris-Saclay, Le Kremlin-Bicêtre, France.
Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Department of Reproductive Endocrinology, Le Kremlin-Bicêtre, France.
Hum Reprod. 2019 Jan 1;34(1):137-147. doi: 10.1093/humrep/dey339.
Does the phenotype of women with normosmic congenital hypogonadotrophic hypogonadism (nCHH) and pituitary resistance to GnRH caused by biallelic mutations in the GnRH receptor (GNRHR) (nCHH/bi-GNRHR) differ from that of women with polycystic ovary syndrome (PCOS)?
Women with nCHH/bi-GNRHR have variable pubertal development but nearly all have primary amenorrhea and an exaggerated LH response to GnRH stimulation, similar to that seen in women with PCOS.
Women with nCHH/bi-GNRHR are very rare and their phenotype at diagnosis is not always adequately documented. The results of gonadotrophin stimulation by acute GnRH challenge test and ovarian features have not been directly compared between these patients and women with PCOS.
STUDY DESIGN, SIZE, DURATION: We describe the phenotypic spectrum at nCHH/bi-GNRHR diagnosis in a series of 12 women. Their reproductive characteristics and acute responses to GnRH were compared to those of 70 women with PCOS.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Patients and controls (healthy female volunteers aged over 18 years) were enrolled in a single French referral centre. Evaluation included clinical and hormonal studies, pelvic ultrasonography and GnRH challenge test. We also functionally characterized two missense GNRHR mutations found in two new consanguineous families.
Breast development was highly variable at nCHH/bi-GNRHR diagnosis, but only one patient had undeveloped breasts. Primary amenorrhea was present in all but two cases. In untreated nCHH/bi-GNRHR patients, uterine height (UH) correlated (P = 0.01) with the circulating estradiol level and was shorter than in 23 nulliparous post-pubertal age-matched controls (P < 0.0001) and than in 15 teenagers with PCOS under 20-years-old (P < 0.0001) in which PCOS was revealed by primary amenorrhea or primary-secondary amenorrhea. Unexpectedly, the stimulated LH peak response in nCHH/bi-GNRHR patients was variable, and often normal or exaggerated. Interestingly, the LH peak response was similar to that seen in the PCOS patients, but the latter women had significantly larger mean ovarian volume (P < 0.001) and uterine length (P < 0.001) and higher mean estradiol (P < 0.001), anti-Müllerian hormone (AMH) (P = 0.02) and inhibin-B (P < 0.001) levels. In the two new consaguineous families, the affected nCHH/bi-GNRHR women carried the T269M or Y290F GNRHR missense mutation in the homozygous state. In vitro analysis of GnRHR showed complete or partial loss-of-function of the T269M and Y290F mutants compared to their wildtype counterpart.
LIMITATIONS, REASONS FOR CAUTION: The number of nCHH/bi-GNRHR patients reported here is small. As this disorder is very rare, an international study would be necessary to recruit a larger cohort and consolidate the phenotypic spectrum observed here.
In teenagers and young women with primary amenorrhea, significant breast and uterine development does not rule out CHH caused by biallelic GNRHR mutations. In rare patients with PCOS presenting with primary amenorrhea and a mild phenotype, the similar exaggerated pituitary LH responses to GnRH in PCOS and nCHH/bi-GNRHR patients could lead to diagnostic errors. This challenge test should therefore not be recommended. As indicated by consensus and guidelines, careful analysis of clinical presentation and measurements of testosterone circulating levels remain the basis of PCOS diagnosis. Also, analysis of ovarian volume, UH and of inhibin-B, AMH, estradiol and androgen circulating levels could help to distinguish between mild PCOS and nCHH/bi-GNRHR.
STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the French National Research Agency (ANR) grant ANR-09-GENO-017 KALGENOPATH, France; and by the Italian Ministry of Education, University and Research (MIUR) grant PRIN 2012227FLF_004, Italy. The authors declare no conflict of interest.
具有正常嗅觉先天性促性腺功能减退性性腺功能减退症(nCHH)和促性腺激素释放激素(GnRH)受体(GNRHR)双等位基因突变引起的垂体抵抗 GnRH 的女性(nCHH/bi-GNRHR)的表型与多囊卵巢综合征(PCOS)女性的表型是否不同?
nCHH/bi-GNRHR 女性的青春期发育存在差异,但几乎所有女性均存在原发性闭经和 GnRH 刺激后的 LH 反应过度,与 PCOS 女性的表现相似。
nCHH/bi-GNRHR 女性非常罕见,其诊断时的表型特征并非总是得到充分记录。这些患者与 PCOS 女性之间的促性腺激素刺激的促性腺激素刺激试验和卵巢特征的结果尚未直接比较。
研究设计、大小、持续时间:我们描述了一系列 12 名 nCHH/bi-GNRHR 女性的诊断时表型谱。比较了她们的生殖特征和对 GnRH 的急性反应与 70 名 PCOS 女性的特征。
参与者/材料、设置、方法:患者和对照(年龄在 18 岁以上的健康女性志愿者)在法国的一个单一转诊中心招募。评估包括临床和激素研究、盆腔超声检查和 GnRH 挑战试验。我们还对在两个新的近亲家庭中发现的两个错义 GNRHR 突变进行了功能表征。
nCHH/bi-GNRHR 诊断时的乳房发育高度可变,但只有一名患者乳房未发育。原发性闭经存在于除两名患者外的所有患者中。在未经治疗的 nCHH/bi-GNRHR 患者中,子宫高度(UH)与循环雌二醇水平相关(P=0.01),且比 23 名无生育能力的青春期后年龄匹配的对照组(P<0.0001)和 15 名 20 岁以下患有 PCOS 的青少年(P<0.0001)短,后者因原发性闭经或原发性-继发性闭经而患有 PCOS。出乎意料的是,nCHH/bi-GNRHR 患者的刺激 LH 峰值反应是可变的,并且常常是正常或过度的。有趣的是,LH 峰值反应与 PCOS 患者相似,但后者的平均卵巢体积(P<0.001)、子宫长度(P<0.001)和雌二醇(P<0.001)、抗苗勒管激素(AMH)(P=0.02)和抑制素-B(P<0.001)水平明显更高。在两个新的近亲家庭中,受影响的 nCHH/bi-GNRHR 女性携带 T269M 或 Y290F GNRHR 错义突变的纯合状态。体外 GnRHR 分析表明,与野生型相比,T269M 和 Y290F 突变体的功能完全或部分丧失。
局限性、谨慎的原因:这里报告的 nCHH/bi-GNRHR 患者数量较少。由于这种疾病非常罕见,需要进行国际研究以招募更大的队列并巩固这里观察到的表型谱。
在青春期和年轻女性中,原发性闭经时显著的乳房和子宫发育并不能排除由双等位基因突变引起的 CHH。在少数以原发性闭经和轻度表型为特征的 PCOS 患者中,PCOS 和 nCHH/bi-GNRHR 患者中类似的过度垂体 LH 对 GnRH 的反应可能导致诊断错误。因此,不建议进行此挑战试验。正如共识和指南所指出的,仔细分析临床表现和循环睾酮水平的测量仍然是 PCOS 诊断的基础。此外,分析卵巢体积、UH 以及抑制素-B、AMH、雌二醇和雄激素的循环水平有助于区分轻度 PCOS 和 nCHH/bi-GNRHR。
研究资金/利益冲突:本研究由法国国家研究署(ANR)资助的 ANR-09-GENO-017 KALGENOPATH 项目和意大利教育部、大学和研究部(MIUR)资助的 PRIN 2012227FLF_004 项目资助。作者声明没有利益冲突。